CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics (Nasdaq: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic ...
SAN LEANDRO, Calif.--(BUSINESS WIRE)--BioClin Therapeutics, Inc., a privately-held clinical stage drug development company, today announced the appointment of Scott Myers as Chief Executive Officer, ...